Company Overview and News
Still a buy: An Ann Joo Resources facility. UOB Kay Hian maintains its ‘buy’ rating on Ann Joo but has reduced its target price to RM3.60 from RM4.50 previously.
KUALA LUMPUR: Choo Bee Metal Industries Bhd ’s shares got a boost in early trade on news of its proposed bonus issue.
KUALA LUMPUR: JF Apex Research expects ViTrox Corp Bhd , Frontken Corp Bhd , Ireka Corp Bhd , Choo Bee Metal Industries Bhd and Pavilion Real Estate Investment Trust (Reit) to generate trading interest following their latest news.
Ready for shipping: A file picture showing steel coils produced at a steel mill in Indiana being prepared for shipping. Local steel stocks have fallen 18.3 after the US announced proposed tariffs on steel and aluminium imports. — AFP
Downtrend: Steel products being stored in an Ann Joo Resources facility. Since the beginning of March, Ann Joo Resources has seen its share price plunging by more than 12.6, Southern Steel Bhd falling almost 10, Hiap Teck Venture Bhd losing more than 12.6, Malaysia Steel Works (KL) Bhd dropping more than 26, CSC Steel Holdings Bhd slipping 8.6 and Choo Bee Metal Industries Bhd declining by more than 10.
Trade dampener: Soh says Trump’s action is uncalled for as high-end steel products for automotive, aeroplane and transportation industries are mostly imported.
Stainless Steel Pipes and Tubes Market has covered and analyzed the potential of Global Stainless Steel Pipe and Tube Market and provides statistics and information on market size, shares and growth factors says a recent research report at ReportsnReports.com
KUALA LUMPUR (Feb 20): The FBM KLCI notched up limited gains at the midday break today as the regional markets remained subdued.
KUALA LUMPUR (Feb 20): The FBM KLCI reversed its earlier loss and moved firmly above the 1,710-point level, lifted by the select blue chips.
KUALA LUMPUR (Feb 20): Shares of steel pipe maker Choo Bee Metal Industries Bhd jumped 8.47% this morning after it saw a more than eightfold jump in net profit for the fourth quarter ended Dec 31, 2016 (4QFY16) on the back of improved average selling price.
KUALA LUMPUR (Feb 20): The FBM KLCI is set to extend its lacklustre run today in line with the slip at most global markets last Friday, but is likely to defend its position above the crucial 1,700-point level.
KUALA LUMPUR (Feb 17): Based on corporate announcements and news flow today, companies that may be in focus on Monday (Feb 20) could include the following: DRB-Hicom, Choo Bee, CB Industrial, Amcorp Properties, Protasco, Sterling Progress, Pintaras Jaya and Sumatec.
KUALA LUMPUR (Sept 19): The FBM KLCI rose 0.47% in early trade today, but gains were seen limited in line with the pensive regional markets.
KUALA LUMPUR (Sept 15): theedgemarkets.com highlighted nine stocks with momentum at Bursa Malaysia's afternoon market close today. Three stocks showed positive momentum, while six displayed negative momentum.
KUALA LUMPUR (Sept 14): theedgemarkets.com highlighted nine stocks with momentum at Bursa Malaysia's afternoon market close today. All nine stocks displayed negative momentum.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...